First robotically assisted coronary stenting procedure performed at Sulpizio Cardiovascular Center

December 23, 2013 by Michelle Brubaker

The interventional cardiology team led by Ehtisham Mahmud, MD, FACC, at UC San Diego Sulpizio Cardiovascular Center (SCVC) has successfully completed the first two robotically-assisted coronary angioplasty/stent procedures in California. Patients with coronary artery disease (CAD) now have access to this new technology that puts the precision of a robot in the hands of interventional cardiologists during procedures to open clogged heart arteries.

The CorPath System designed by Corindus Vascular Robotics (Natick, MA), offers interventional cardiologists unparalleled control in catheterization laboratories (cath labs) while performing coronary angioplasty and stenting.

"Sitting a few feet away from the patient's bedside at a computerized work station, I was able to navigate and advance the guidewire, balloon catheter and stent through the coronary artery. The ability to accurately measure lesion length with this technology enabled me to identify the exact length of the stents required and precisely place them," said Mahmud, chief of cardiovascular medicine and director of the SCVC-Medicine.

The first patient treated was a 66-year-old woman who had previously undergone graft surgery and required stenting of a 90 percent blockage in her native artery. The second patient was a 61-year-old man with a severe 95 percent blockage of his who presented with unstable angina.

CAD is characterized by plaque buildup that restricts blood flow in the arteries and is a widespread and life-threatening disease. In addition to medical therapy, angioplasty and stenting are the most common treatment for CAD. During the minimally invasive procedure, a tiny balloon is used to physically open an and help improve blood flow. Interventional cardiologists then use drug-eluting stents, wire metal mesh tubes, to prop open the arteries and keep them open following the procedure. There are nearly one million angioplasties performed annually in the nation.

The new robotic system acts as an "extra hand" that holds cardiac devices in place during the entirety of an interventional procedure. Furthermore, the entire procedure is performed with minimal radiation exposure to the operator, resulting in shorter procedure time and enables the delivery of cost-effective care.

"As the only comprehensive academic health system in the region, we are honored to be the first hospital in the state to deliver this technology to patients and the community," said Mahmud.

The interventional cardiovascular team at the SCVC, led by Mahmud, performs a high volume of complex interventional procedures and offers patients comprehensive, cutting edge treatment for the entire spectrum of cardiovascular disease.

Explore further: Fully dissolvable, temporary stent for opening heart artery blockages

Related Stories

Fully dissolvable, temporary stent for opening heart artery blockages

September 17, 2013
The Mount Sinai Medical Center is participating in the nationwide ABSORB III clinical trial testing the performance and potential clinical benefits of a fully dissolvable and temporary drug eluting stent to open heart artery ...

Angioplasty possibly no better than drug therapy

December 9, 2013
For patients with stable coronary artery disease (CAD) who are not experiencing a heart attack and an abnormal stress test, treatment of their narrowed arteries by the common procedure of angioplasty may not provide additional ...

Cleveland Clinic study finds lowest risk treatment for severe carotid and coronary disease

July 31, 2013
Of the three most common treatment approaches for patients with severe carotid and coronary artery disease, patients who underwent stenting of the carotid artery followed by open heart surgery had the best outcomes, according ...

Results of the HYBRID trial presented

October 31, 2013
A hybrid approach to treating coronary artery disease that involves a "hybrid procedure" combining a minimally invasive bypass surgery with percutaneous coronary intervention (PCI) was found to be feasible and safe in a clinical ...

Skip the balloon after placing carotid stent, surgeons suggest

December 11, 2013
Johns Hopkins surgeons say skipping one commonly taken step during a routine procedure to insert a wire mesh stent into a partially blocked carotid artery appears to prevent patients from developing dangerously low blood ...

Stroke risk higher after bypass than angioplasty: analysis

August 21, 2012
(HealthDay News) -- The potential for a stroke is far more common after a bypass than after angioplasty, new research reports, even though the risk after either heart procedure is still relatively low.

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.